CLINICAL_TRIALS
trial_result
· 2013-01-11
Clinical Trial Update: A Phase 3 Study Comparing 2 Doses of CP-690,550 vs. Placebo for Treatment of Rheumatoid Arthritis [Phase 3]
Summary
Phase 3 trial comparing two doses of CP-690,550 (tofacitinib) against placebo in rheumatoid arthritis; results have been posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Pfizer | Conditions: Arthritis, Rheumatoid | Phase 3 | Status: COMPLETED | Results posted: 2013-01-11